TCF7L1 anticorps (N-Term)
Aperçu rapide pour TCF7L1 anticorps (N-Term) (ABIN1109209)
Antigène
Voir toutes TCF7L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- NDELIPFQDE GGEEQEPSSD SASAQRDLDE VKSSLVNESE NQSSSSDSEA
-
Réactivité croisée (Details)
- Species reactivity (expected):Mouse, Guinea Pig, RabbitSpecies reactivity (tested):Human
-
Purification
- Purified on peptide immunoaffinity column
-
Immunogène
- Synthetic peptide directed towards the N terminal of human TCF7L1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Add 50 μL of distilled water
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store the lyophised antibody at -20 °C for up to one year. Store reconstitued antibody undiluted for one month or in aliquots at -20 °C long term.
-
Date de péremption
- 12 months
-
-
- TCF7L1 (Transcription Factor 7-Like 1 (T-Cell Specific, HMG-Box) (TCF7L1))
-
Autre désignation
- TCF7L1
-
Sujet
- TCF7L1 participates in the Wnt signaling pathway. It binds to DNA and acts as a repressor in the absence of CTNNB1, and as an activator in its presence. It is necessary for the terminal differentiation of epidermal cells, the formation of keratohyalin granules and the development of the barrier function of the epidermis. TCF7L1 down-regulates NQO1, leading to increased mitomycin c resistance.Synonyms: HMG box transcription factor 3, TCF-3, TCF3, Transcription factor 7-like 1
-
ID gène
- 83439
-
NCBI Accession
- NP_112573
-
Pathways
- Signalisation WNT, Stem Cell Maintenance
Antigène
-